Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (9) , 2692-2696
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Potent transglutaminase inhibitors, aryl β-aminoethyl ketonesBioorganic & Medicinal Chemistry Letters, 2010
- Targeting Structural and Stereochemical Complexity by Organocascade Catalysis: Construction of Spirocyclic Oxindoles Having Multiple StereocentersAngewandte Chemie International Edition, 2009
- Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-β Activation and Cell InfiltrationThe American Journal of Pathology, 2008
- Identification of Chemical Inhibitors to Human Tissue Transglutaminase by Screening Existing Drug LibrariesChemistry & Biology, 2008
- Regioselective Synthesis of Novel Dispiro‐oxindoloindenoquinoxaline Pyrrolidines through 1,3‐Dipolar Cycloaddition MethodologySynthetic Communications, 2008
- Transglutaminase 2 Undergoes a Large Conformational Change upon ActivationPLOS Biology, 2007
- Enantioselective Construction of Spirocyclic Oxindolic Cyclopentanes by Palladium-Catalyzed Trimethylenemethane-[3+2]-CycloadditionJournal of the American Chemical Society, 2007
- Transglutaminase 2 inhibitors and their therapeutic role in disease statesPharmacology & Therapeutics, 2007
- Structure−Activity Relationship Analysis of the Selective Inhibition of Transglutaminase 2 by DihydroisoxazolesJournal of Medicinal Chemistry, 2006
- Structure–activity relationship study of novel tissue transglutaminase inhibitorsBioorganic & Medicinal Chemistry Letters, 2005